SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-002481
Filing Date
2019-02-25
Accepted
2019-02-25 07:32:08
Documents
105
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2002122
2 logo_001.jpg GRAPHIC 40721
3 ex10-62.htm EX-10.62 467773
4 ex10-63.htm EX-10.63 146273
5 ex10-64.htm EX-10.64 44101
6 ex10-65.htm EX-10.65 25473
7 ex10-66.htm EX-10.66 51431
8 ex21-1.htm EX-21.1 4501
9 ex23-1.htm EX-23.1 4736
10 ex31-1.htm EX-31.1 19041
11 ex31-2.htm EX-31.2 17824
12 ex32-1.htm EX-32.1 5941
13 ex32-2.htm EX-32.2 6639
  Complete submission text file 0001493152-19-002481.txt   7678292

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE vbiv-20181231.xml EX-101.INS 1016877
15 XBRL SCHEMA FILE vbiv-20181231.xsd EX-101.SCH 78218
16 XBRL CALCULATION FILE vbiv-20181231_cal.xml EX-101.CAL 80218
17 XBRL DEFINITION FILE vbiv-20181231_def.xml EX-101.DEF 309060
18 XBRL LABEL FILE vbiv-20181231_lab.xml EX-101.LAB 498177
19 XBRL PRESENTATION FILE vbiv-20181231_pre.xml EX-101.PRE 414089
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37769 | Film No.: 19628073
SIC: 2834 Pharmaceutical Preparations